CG MedTech시지메드텍
056090 · KOSDAQ · ₩056090 · 시지메드텍
₩4,370▼ ₩75 (1.69%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 41.7% | 44.8% | 46.6% | 52.2% | 46.3% | 41.7% |
| Operating margin | 3.7% | 8.1% | −3.2% | −4.6% | 1.0% | −2.1% |
| Net margin | 12.8% | 13.8% | −0.4% | 3.7% | −45.0% | −13.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +8.4% | +36.4% | −1.0% | −15.1% | +8.2% | — |
| Operating income growth | −50.5% | +441.7% | +31.2% | −482.6% | +152.0% | — |
| Net income growth | +0.7% | +5,308.7% | −109.6% | +107.0% | −273.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 6.9% | 7.2% | −0.2% | 2.2% | −43.0% | −17.4% |
| Return on assets | 5.3% | 5.9% | −0.1% | 1.2% | −17.4% | −6.9% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 39.4% | 22.1% | 23.6% | 32.1% | 145.2% | 160.8% |
| Net debt to equity | 8.4% | −8.2% | −35.4% | −18.4% | 73.5% | 59.2% |
| Current ratio | 210.4% | 212.3% | 455.7% | 384.1% | 130.4% | 178.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: CG MedTech / 시지메드텍 / 056090 / KRX:056090
Source: KRX statistical information